FOREWORD

This, third, issue of Current Neuropharmacology marks a new departure from the format of previous issues. As part of this issue there is a special section of review papers centred around the theme of Gabapentin, a drug originally developed as an anti-epileptic but which has found uses in other spheres of clinical practice. The papers in this special section range from basic research to clinical findings with this drug, and these papers are introduced by the Guest Editor, Dr Rod Scott. It is a great pleasure to acknowledge the work which Rod has done in bringing this excellent range of papers together, and we hope that this will prove to be a valuable contribution to the understanding of the mechanisms of action of this drug. It is planned to compile special issues on other Hot Topics in the future, and I would welcome suggestions for suitable topics.